Skip to main content

Table 3 Effects of monomeric compounds with different JSKL concentrations on the activity of MH7A cells

From: Anti-inflammatory effects of Jingshu Keli capsule and its components on human synoviocyte MH7A cells

SamplesJSKL Concentrations (μM)
00.1110
Ferulic acid1.930 ± 0.0442.048 ± 0.0250.817 ± 0.111**0.255 ± 0.072**
CIN(1/20)1.430 ± 0.0731.692 ± 0.197*1.633 ± 0.165*1.538 ± 0.192
Cholic acid1.140 ± 0.0511.090 ± 0.1220.997 ± 0.053*1.118 ± 0.074
Gastrodin1.930 ± 0.0991.973 ± 0.0321.934 ± 0.0211.987 ± 0.089
Notoginsenoside R11.723 ± 0.0392.018 ± 0.4132.281 ± 0.379*2.046 ± 0.094*
Ginsenoside Rg11.723 ± 0.172.007 ± 0.052*2.257 ± 0.152*1.685 ± 0.147
Ginsenoside Rb11.723 ± 0.0171.942 ± 0.110*2.184 ± 0.151*2.074 ± 0.131*
  1. Note:1/20: the actual concentration of CIN was 1/20 times of the label concentration, which means 0, 0.005, 0.05, 0.5 μM from left to right. 0 μM was defined as the control group. Data are expressed as means ± SD (N = 5). *p < 0.05, **p < 0.01 vs. control group